Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SAE1 pseudogene 1 (SAE1P1) is a pseudogene of the SAE1 (SUMO1 activating enzyme subunit 1) locus[3]. Pseudogenes are genomic sequences that closely resemble functional genes but have lost their ability to encode a functional protein due to mutations, lack of regulatory elements, or genomic rearrangements[4][5]. SAE1 itself is a subunit in the SUMO-activating enzyme complex, participating in the post-translational modification process known as sumoylation, which regulates protein structure and localization[1]. However, SAE1P1 does not encode a functional protein and is not considered a biological or therapeutic target.
None. As above, pseudogenes are not drug targets and have no known pharmacological mechanisms[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SAE1 pseudogene 1 (SAE1P1).